Trademark: 79354991
Word
REPHINE
Status Date
Tuesday, April 30, 2024
Registration Number
7369558
Registration Date
Tuesday, April 30, 2024
Filing Date
Tuesday, June 7, 2022
Published for Opposition
Tuesday, February 13, 2024
45 Regulatory compliance auditing; legal compliance auditing; good manufacturing practices audit in the nature of legal compliance auditing; advisory services relating to regulatory affairs in the field of the manufacture of pharmaceuticals; reviewing standards and practices to assure compliance with manufacturing process safety, product safety and product packaging laws and regulations; legal and regulatory information services relating to pharmaceutical manufacturing standards; analysis of data, policy and process, and provision of advice and assistance relating to standards and practices to ensure compliance with manufacturing process safety, product safety and product packaging laws and regulations; legal and regulatory compliance consulting services in the field of the manufacture of pharmaceuticals; legal and regulatory advisory and consultancy services in relation to clinical trials; provision of information and advice relating to regulatory compliance systems in the field of the manufacture of pharmaceuticals; legal services, namely, legal risk assessment services for the security of goods and individuals; project management consulting services relating to regulatory compliance requirements for pharmaceutical manufacturing safety and security; regulatory compliance consulting in the field of the manufacture of pharmaceuticals, namely, provision of benchmarking and reference information relating to pharmaceutical safety standards; information, advisory and consultancy services in relation to the aforesaid
42 Pharmaceutical product evaluation; quality audits in the nature of product quality evaluation; product quality control testing; product safety testing services; testing services in the field of manufacturing safety; quality assurance consultancy in the field of pharmaceuticals and the manufacture of pharmaceuticals; inspection services of pharmaceuticals and manufacturing processes for pharmaceuticals for quality control; inspection of manufacturing processes to determine conformance with certification standards for quality, reliability, and safety; inspection of pharmaceuticals; product quality testing services; testing of pharmaceuticals; quality control for others to determine conformance with established product certification standards; product quality evaluation services in the nature of quality control for others; industrial analysis services in the field of pharmaceuticals and manufacturing processes for pharmaceuticals; testing, inspection, quality control, evaluation, verification and analysis of medical products and pharmaceuticals for others; testing, inspection, quality control, verification, evaluation and analysis of medical products and pharmaceuticals for others for compliance with quality standards; testing, quality control inspection, evaluation, verification and analysis of quality management systems, manufacturing systems, manufacturing methods and manufacturing processes; conducting clinical trials for others; scientific research in the nature of scientific study protocol development; research and development in the pharmaceutical field; information, advisory and consultancy services in relation to the aforesaid
Nov 10, 2022
Sn Assigned For Sect 66a Appl From Ib
Apr 4, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Nov 14, 2022
New Application Office Supplied Data Entered
Nov 18, 2022
Application Filing Receipt Mailed
Mar 22, 2023
Assigned To Examiner
Apr 3, 2023
Non-Final Action Written
Jun 1, 2023
Refusal Processed By Mpu
Jun 1, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jun 18, 2023
Refusal Processed By Ib
Jun 20, 2023
Teas Response To Office Action Received
Jun 20, 2023
Correspondence Received In Law Office
Jun 21, 2023
Teas/Email Correspondence Entered
Jul 17, 2023
Examiners Amendment -Written
Jul 17, 2023
Examiners Amendment E-Mailed
Jul 17, 2023
Notification Of Examiners Amendment E-Mailed
Jul 17, 2023
Examiner's Amendment Entered
Sep 14, 2023
Examiners Amendment -Written
Sep 14, 2023
Examiners Amendment E-Mailed
Sep 14, 2023
Notification Of Examiners Amendment E-Mailed
Sep 14, 2023
Examiner's Amendment Entered
Sep 18, 2023
Approved For Pub - Principal Register
Oct 3, 2023
Withdrawn From Pub - Og Review Query
Nov 14, 2023
Previous Allowance Count Withdrawn
Nov 22, 2023
Examiners Amendment -Written
Nov 22, 2023
Examiners Amendment E-Mailed
Nov 22, 2023
Notification Of Examiners Amendment E-Mailed
Nov 22, 2023
Examiner's Amendment Entered
Nov 22, 2023
Approved For Pub - Principal Register
Jan 10, 2024
Assigned To Lie
Jan 24, 2024
Notification Of Possible Opposition Sent To Ib
Jan 24, 2024
Notification Of Notice Of Publication E-Mailed
Jan 24, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 13, 2024
Published For Opposition
Feb 13, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 10, 2024
Notification Of Possible Opposition Sent To Ib
Apr 30, 2024
Notice Of Registration Confirmation Emailed
Jan 10, 2024
Law Office Publication Review Completed
Feb 14, 2024
Notification Processed By Ib
Apr 10, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 29, 2024
Notification Of Possible Opposition - Processed By Ib
Apr 30, 2024
Registered-Principal Register
Jul 30, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
